Leaving Covid safety to personal choice will ‘come back to bite us,’ ex-Obama health official says

Leaving Covid safety to personal choice will ‘come back to bite us,’ ex-Obama health official says


A former Obama health policy director on Monday criticized what she sees as a potentially dangerous shift in government messaging on Covid safety protocols.

“My biggest issue with the it’s-your-call kind of theme that’s out there [is] we don’t do this in any other area of illness, health, or disease or burden. I don’t tell a patient with high LDL cholesterol, ‘Hey, you go figure out what your 10-year cardiovascular risk is, and you can decide,'” Dr. Kavita Patel said on CNBC’s “Squawk Box.”

“Of course, they are able to decide what their options are after I talk to them about what I think is best,” added Patel, a primary care physician in the Washington, D.C. area.

Patel’s comments come after a report in The Wall Street Journal that characterized a new emphasis from federal and local health officials on personal choice when it comes to receiving booster shots, masking or following other Covid mitigation measures.

The Centers for Disease Control and Prevention was not immediately available for comment on Patel’s remarks.

The White House released a new plan to tackle the pandemic in March, highlighting four key areas where the Biden administration hopes to secure funding. White House coronavirus response coordinator Dr. Ashish Jha said on NBC’s “Meet the Press” on Sunday that “we’re going to have to pay very close attention” to the uptick in omicron BA.2 subvariant cases. Congress did not renew emergency federal aid for some pandemic programs.

Patel said that health officials’ essentially giving Americans autonomy over Covid decisions is bound to cause confusion.

“That just seems like a very poor way for a country that has been told for two years, ‘Here’s what you need to do, here’s how you need to do it,’ and now we do what, tell people to go to covid.gov and cross their fingers and hope that they can navigate the site and get to treatment?” she said.

“I think that this is unfortunately going to come back to bite us, because we’re not necessarily doing the types of things we should be doing,” Patel concluded.



Source

E.l.f. Beauty posts earnings beat, raises full-year guidance
Business

E.l.f. Beauty posts earnings beat, raises full-year guidance

Elf Beauty cosmetics Courtesy: e.l.f Beauty E.l.f. Beauty reported a huge earnings beat Wednesday and raised its guidance for the fiscal year. E.l.f. stock was up as much as 15% in after-hours trading before losing the majority of those gains. Here’s what the company reported for the third fiscal quarter, compared with analyst estimates from […]

Read More
Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs
Business

Terrell Owens calls Hall of Fame process ‘broken’ after Belichick, Kraft snubs

NFL Hall of Famer Terrell Owens said Wednesday that the recent snubs of New England Patriots owner Robert Kraft and former coach Bill Belichick from the institution show the system is flawed, and someone needs to be held accountable. “It’s just plain dumb” Owens told CNBC Sport in an interview in San Francisco ahead of […]

Read More
Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
Business

Eli Lilly’s GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It’s a tale of two drugmakers in the red-hot obesity drug market.  Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S., but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline, […]

Read More